BIOMAT Database Logo BIOMAT Database Logo

p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas. 2001

A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Department of Chemistry Research, Bayer Research Center, Pharmaceutical Division, West Haven, CT 06516, USA. aniko.redman.b@bayer.com

Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range.

UI MeSH Term Description Entries
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
[Synthesis and mass spectroscopic analysis of some tert.-butyl thienyl-, pyrrolyl- and furyl-carbamates (author's transl)].
March 1975, Archiv der Pharmazie,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.
September 2000, Bioorganic & medicinal chemistry letters,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis.
May 2003, Current opinion in investigational drugs (London, England : 2000),
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Design, synthesis and characterization of N', N"-diaryl ureas as p38 kinase inhibitors.
March 2013, Medicinal chemistry (Shariqah (United Arab Emirates)),
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitors.
January 2004, Bioorganic & medicinal chemistry letters,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Pyrrolyl-, 2-(2-thienyl)pyrrolyl- and 2,5-bis(2-thienyl)pyrrolyl-nucleosides: synthesis, molecular and electronic structure, and redox behaviour of C5-thymidine derivatives.
March 2011, Organic & biomolecular chemistry,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
A novel series of p38 MAP kinase inhibitors for the potential treatment of rheumatoid arthritis.
November 2004, Bioorganic & medicinal chemistry letters,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma.
May 2022, Journal of personalized medicine,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Kinase inhibitors for the treatment of rheumatoid arthritis.
January 2012, Bulletin of the NYU hospital for joint diseases,
A M Redman, and J S Johnson, and R Dally, and S Swartz, and H Wild, and H Paulsen, and Y Caringal, and D Gunn, and J Renick, and M Osterhout, and J Kingery-Wood, and R A Smith, and W Lee, and J Dumas, and S M Wilhelm, and T J Housley, and A Bhargava, and G E Ranges, and A Shrikhande, and D Young, and M Bombara, and W J Scott
Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.
January 2013, Current topics in medicinal chemistry,
Copied contents to your clipboard!